The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Goodwin

100 NORTHERN AVENUE, BOSTON MA 02210, USA
Tel:
Work +617 570 1000
Fax:
Fax +617 523 1231
Email:
Web:
www.goodwinlaw.com

Mark Bettencourt

Tel:
Work +1 617 570 1091
Email:
Goodwin

Position

Partner

Career

Mark Bettencourt, a partner in Goodwin Procter's Technology & Life Sciences Group, concentrates in general corporate and securities law and has extensive experience in mergers and acquisitions, public offerings, private placements of debt and equity securities, securities law compliance, and technology transfer and licensing. Mr. Bettencourt serves as Chairman of the firm's Business Law Department and on its Management and Executive Committees. He works with companies from their initial financing through successful initial public offerings or acquisitions. A significant portion of Mr. Bettencourt's practice involves cross-border acquisitions and financings. He regularly counsels non-U.S. technology companies in connection with their U.S. operations.

Education

J.D., 1994 New York University School of Law (cum laude) B.A., 1991 University of Notre Dame (with high honors)


United States: M&A/corporate and commercial

M&A: middle-market ($500m-999m)

Within: M&A: middle-market ($500m-999m)

Goodwin advises both buyers and sellers in transactions, including asset deals, stock deals, mergers, joint ventures and bankruptcy deals, and has longstanding experience in the technology, life sciences, business services, real estate, financial services and healthcare sectors. The firm also has a robust private equity practice. It advised EPR Properties on its acquisition of CNL Lifestyle Properties, together with co-buyer Och-Ziff Real Estate; and acted for biotechnology company Delinia in its sale to Celgene Corporation, which planned to expand its inflammation and immunology pipeline with Delinia’s preclinical-stage regulatory T cell therapy. Large deal matters included acting for biopharmaceutical services company PAREXEL International in its sale to Pamplona Capital Management; and assisting Albany Molecular Research with its sale to affiliates of The Carlyle Group and GTCR. Boston-based Mark Bettencourt advises private and public companies in the software, internet, digital media, robotics, communications, and networking equipment and information services industries; and Stuart Cable currently serves as chair of the M&A and corporate finance practices for the firm’s technology and life science business units. Other highly rated Boston practitioners include Joseph Johnson III, John Egan III, John Haggerty and John LeClaire. Silicon Valley-based Lawrence Chu, Joshua Klatzkin in Washington DC, Andrew Weidhaas, who divides his time between Los Angeles and New York, and Los Angeles-based Stephen Lee are also experienced practitioners.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to